Global Anti-Obesity Drugs Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery
Anti-obesity drugs are the drugs that help in reducing or controlling body mass, either by decreasing the craving or increasing the consumption of calories. Appetite control is achieved through the use of agonists for appetite suppressing pathways.
Based on the Anti-Obesity Drugs market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Anti-Obesity Drugs market covered in Chapter 5:
Vivus
Zafgen
Takeda Pharmaceutical
Bristol-Myers Squibb
Novo Nordisk
F. Hoffmann La Roche
Rhythm Pharmaceuticals
Eisai Co, Ltd.
Orexigen Therapeutics
FlaxoSithKline plc
Pfizer
Shionogi USA
Alizyme
Norgine Pharmaceuticals Ltd.
GlaxoSmithKline
BoehringerIngelheim GmbH
In Chapter 6, on the basis of types, the Anti-Obesity Drugs market from 2015 to 2025 is primarily split into:
Prescription Drugs
OTC Drugs
In Chapter 7, on the basis of applications, the Anti-Obesity Drugs market from 2015 to 2025 covers:
Men
Women
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Based on the Anti-Obesity Drugs market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Anti-Obesity Drugs market covered in Chapter 5:
Vivus
Zafgen
Takeda Pharmaceutical
Bristol-Myers Squibb
Novo Nordisk
F. Hoffmann La Roche
Rhythm Pharmaceuticals
Eisai Co, Ltd.
Orexigen Therapeutics
FlaxoSithKline plc
Pfizer
Shionogi USA
Alizyme
Norgine Pharmaceuticals Ltd.
GlaxoSmithKline
BoehringerIngelheim GmbH
In Chapter 6, on the basis of types, the Anti-Obesity Drugs market from 2015 to 2025 is primarily split into:
Prescription Drugs
OTC Drugs
In Chapter 7, on the basis of applications, the Anti-Obesity Drugs market from 2015 to 2025 covers:
Men
Women
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
1 MARKET OVERVIEW
1.1 Product Definition and Market Characteristics
1.2 Global Anti-Obesity Drugs Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis
2. MARKET DYNAMICS
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact
3 ASSOCIATED INDUSTRY ASSESSMENT
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain
4 MARKET COMPETITIVE LANDSCAPE
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans
5 ANALYSIS OF LEADING COMPANIES
5.1 Vivus
5.1.1 Vivus Company Profile
5.1.2 Vivus Business Overview
5.1.3 Vivus Anti-Obesity Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Vivus Anti-Obesity Drugs Products Introduction
5.2 Zafgen
5.2.1 Zafgen Company Profile
5.2.2 Zafgen Business Overview
5.2.3 Zafgen Anti-Obesity Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 Zafgen Anti-Obesity Drugs Products Introduction
5.3 Takeda Pharmaceutical
5.3.1 Takeda Pharmaceutical Company Profile
5.3.2 Takeda Pharmaceutical Business Overview
5.3.3 Takeda Pharmaceutical Anti-Obesity Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 Takeda Pharmaceutical Anti-Obesity Drugs Products Introduction
5.4 Bristol-Myers Squibb
5.4.1 Bristol-Myers Squibb Company Profile
5.4.2 Bristol-Myers Squibb Business Overview
5.4.3 Bristol-Myers Squibb Anti-Obesity Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Bristol-Myers Squibb Anti-Obesity Drugs Products Introduction
5.5 Novo Nordisk
5.5.1 Novo Nordisk Company Profile
5.5.2 Novo Nordisk Business Overview
5.5.3 Novo Nordisk Anti-Obesity Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 Novo Nordisk Anti-Obesity Drugs Products Introduction
5.6 F. Hoffmann La Roche
5.6.1 F. Hoffmann La Roche Company Profile
5.6.2 F. Hoffmann La Roche Business Overview
5.6.3 F. Hoffmann La Roche Anti-Obesity Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 F. Hoffmann La Roche Anti-Obesity Drugs Products Introduction
5.7 Rhythm Pharmaceuticals
5.7.1 Rhythm Pharmaceuticals Company Profile
5.7.2 Rhythm Pharmaceuticals Business Overview
5.7.3 Rhythm Pharmaceuticals Anti-Obesity Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 Rhythm Pharmaceuticals Anti-Obesity Drugs Products Introduction
5.8 Eisai Co, Ltd.
5.8.1 Eisai Co, Ltd. Company Profile
5.8.2 Eisai Co, Ltd. Business Overview
5.8.3 Eisai Co, Ltd. Anti-Obesity Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 Eisai Co, Ltd. Anti-Obesity Drugs Products Introduction
5.9 Orexigen Therapeutics
5.9.1 Orexigen Therapeutics Company Profile
5.9.2 Orexigen Therapeutics Business Overview
5.9.3 Orexigen Therapeutics Anti-Obesity Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.9.4 Orexigen Therapeutics Anti-Obesity Drugs Products Introduction
5.10 FlaxoSithKline plc
5.10.1 FlaxoSithKline plc Company Profile
5.10.2 FlaxoSithKline plc Business Overview
5.10.3 FlaxoSithKline plc Anti-Obesity Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.10.4 FlaxoSithKline plc Anti-Obesity Drugs Products Introduction
5.11 Pfizer
5.11.1 Pfizer Company Profile
5.11.2 Pfizer Business Overview
5.11.3 Pfizer Anti-Obesity Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.11.4 Pfizer Anti-Obesity Drugs Products Introduction
5.12 Shionogi USA
5.12.1 Shionogi USA Company Profile
5.12.2 Shionogi USA Business Overview
5.12.3 Shionogi USA Anti-Obesity Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.12.4 Shionogi USA Anti-Obesity Drugs Products Introduction
5.13 Alizyme
5.13.1 Alizyme Company Profile
5.13.2 Alizyme Business Overview
5.13.3 Alizyme Anti-Obesity Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.13.4 Alizyme Anti-Obesity Drugs Products Introduction
5.14 Norgine Pharmaceuticals Ltd.
5.14.1 Norgine Pharmaceuticals Ltd. Company Profile
5.14.2 Norgine Pharmaceuticals Ltd. Business Overview
5.14.3 Norgine Pharmaceuticals Ltd. Anti-Obesity Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.14.4 Norgine Pharmaceuticals Ltd. Anti-Obesity Drugs Products Introduction
5.15 GlaxoSmithKline
5.15.1 GlaxoSmithKline Company Profile
5.15.2 GlaxoSmithKline Business Overview
5.15.3 GlaxoSmithKline Anti-Obesity Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.15.4 GlaxoSmithKline Anti-Obesity Drugs Products Introduction
5.16 BoehringerIngelheim GmbH
5.16.1 BoehringerIngelheim GmbH Company Profile
5.16.2 BoehringerIngelheim GmbH Business Overview
5.16.3 BoehringerIngelheim GmbH Anti-Obesity Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.16.4 BoehringerIngelheim GmbH Anti-Obesity Drugs Products Introduction
6 MARKET ANALYSIS AND FORECAST, BY PRODUCT TYPES
6.1 Global Anti-Obesity Drugs Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Anti-Obesity Drugs Sales and Market Share by Types (2015-2020)
6.1.2 Global Anti-Obesity Drugs Revenue and Market Share by Types (2015-2020)
6.1.3 Global Anti-Obesity Drugs Price by Types (2015-2020)
6.2 Global Anti-Obesity Drugs Market Forecast by Types (2020-2025)
6.2.1 Global Anti-Obesity Drugs Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Anti-Obesity Drugs Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Anti-Obesity Drugs Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Anti-Obesity Drugs Sales, Price and Growth Rate of Prescription Drugs
6.3.2 Global Anti-Obesity Drugs Sales, Price and Growth Rate of OTC Drugs
6.4 Global Anti-Obesity Drugs Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 Prescription Drugs Market Revenue and Sales Forecast (2020-2025)
6.4.2 OTC Drugs Market Revenue and Sales Forecast (2020-2025)
7 MARKET ANALYSIS AND FORECAST, BY APPLICATIONS
7.1 Global Anti-Obesity Drugs Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global Anti-Obesity Drugs Sales and Market Share by Applications (2015-2020)
7.1.2 Global Anti-Obesity Drugs Revenue and Market Share by Applications (2015-2020)
7.2 Global Anti-Obesity Drugs Market Forecast by Applications (2020-2025)
7.2.1 Global Anti-Obesity Drugs Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global Anti-Obesity Drugs Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global Anti-Obesity Drugs Revenue, Sales and Growth Rate of Men (2015-2020)
7.3.2 Global Anti-Obesity Drugs Revenue, Sales and Growth Rate of Women (2015-2020)
7.4 Global Anti-Obesity Drugs Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 Men Market Revenue and Sales Forecast (2020-2025)
7.4.2 Women Market Revenue and Sales Forecast (2020-2025)
8 MARKET ANALYSIS AND FORECAST, BY REGIONS
8.1 Global Anti-Obesity Drugs Sales by Regions (2015-2020)
8.2 Global Anti-Obesity Drugs Market Revenue by Regions (2015-2020)
8.3 Global Anti-Obesity Drugs Market Forecast by Regions (2020-2025)
9 NORTH AMERICA ANTI-OBESITY DRUGS MARKET ANALYSIS
9.1 Market Overview and Prospect Analysis
9.2 North America Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
9.3 North America Anti-Obesity Drugs Market Revenue and Growth Rate (2015-2020)
9.4 North America Anti-Obesity Drugs Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Anti-Obesity Drugs Market Analysis by Country
9.6.1 U.S. Anti-Obesity Drugs Sales and Growth Rate
9.6.2 Canada Anti-Obesity Drugs Sales and Growth Rate
9.6.3 Mexico Anti-Obesity Drugs Sales and Growth Rate
10 EUROPE ANTI-OBESITY DRUGS MARKET ANALYSIS
10.1 Market Overview and Prospect Analysis
10.2 Europe Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
10.3 Europe Anti-Obesity Drugs Market Revenue and Growth Rate (2015-2020)
10.4 Europe Anti-Obesity Drugs Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Anti-Obesity Drugs Market Analysis by Country
10.6.1 Germany Anti-Obesity Drugs Sales and Growth Rate
10.6.2 United Kingdom Anti-Obesity Drugs Sales and Growth Rate
10.6.3 France Anti-Obesity Drugs Sales and Growth Rate
10.6.4 Italy Anti-Obesity Drugs Sales and Growth Rate
10.6.5 Spain Anti-Obesity Drugs Sales and Growth Rate
10.6.6 Russia Anti-Obesity Drugs Sales and Growth Rate
11 ASIA-PACIFIC ANTI-OBESITY DRUGS MARKET ANALYSIS
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Anti-Obesity Drugs Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Anti-Obesity Drugs Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Anti-Obesity Drugs Market Analysis by Country
11.6.1 China Anti-Obesity Drugs Sales and Growth Rate
11.6.2 Japan Anti-Obesity Drugs Sales and Growth Rate
11.6.3 South Korea Anti-Obesity Drugs Sales and Growth Rate
11.6.4 Australia Anti-Obesity Drugs Sales and Growth Rate
11.6.5 India Anti-Obesity Drugs Sales and Growth Rate
12 SOUTH AMERICA ANTI-OBESITY DRUGS MARKET ANALYSIS
12.1 Market Overview and Prospect Analysis
12.2 South America Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
12.3 South America Anti-Obesity Drugs Market Revenue and Growth Rate (2015-2020)
12.4 South America Anti-Obesity Drugs Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Anti-Obesity Drugs Market Analysis by Country
12.6.1 Brazil Anti-Obesity Drugs Sales and Growth Rate
12.6.2 Argentina Anti-Obesity Drugs Sales and Growth Rate
12.6.3 Columbia Anti-Obesity Drugs Sales and Growth Rate
13 MIDDLE EAST AND AFRICA ANTI-OBESITY DRUGS MARKET ANALYSIS
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Anti-Obesity Drugs Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Anti-Obesity Drugs Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Anti-Obesity Drugs Market Analysis by Country
13.6.1 UAE Anti-Obesity Drugs Sales and Growth Rate
13.6.2 Egypt Anti-Obesity Drugs Sales and Growth Rate
13.6.3 South Africa Anti-Obesity Drugs Sales and Growth Rate
14 CONCLUSIONS AND RECOMMENDATIONS
14.1 Key Market Findings and Prospects
14.2 Advice for Investors
15 APPENDIX
15.1 Methodology
15.2 Research Data Source
1.1 Product Definition and Market Characteristics
1.2 Global Anti-Obesity Drugs Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis
2. MARKET DYNAMICS
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact
3 ASSOCIATED INDUSTRY ASSESSMENT
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain
4 MARKET COMPETITIVE LANDSCAPE
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans
5 ANALYSIS OF LEADING COMPANIES
5.1 Vivus
5.1.1 Vivus Company Profile
5.1.2 Vivus Business Overview
5.1.3 Vivus Anti-Obesity Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Vivus Anti-Obesity Drugs Products Introduction
5.2 Zafgen
5.2.1 Zafgen Company Profile
5.2.2 Zafgen Business Overview
5.2.3 Zafgen Anti-Obesity Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 Zafgen Anti-Obesity Drugs Products Introduction
5.3 Takeda Pharmaceutical
5.3.1 Takeda Pharmaceutical Company Profile
5.3.2 Takeda Pharmaceutical Business Overview
5.3.3 Takeda Pharmaceutical Anti-Obesity Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 Takeda Pharmaceutical Anti-Obesity Drugs Products Introduction
5.4 Bristol-Myers Squibb
5.4.1 Bristol-Myers Squibb Company Profile
5.4.2 Bristol-Myers Squibb Business Overview
5.4.3 Bristol-Myers Squibb Anti-Obesity Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Bristol-Myers Squibb Anti-Obesity Drugs Products Introduction
5.5 Novo Nordisk
5.5.1 Novo Nordisk Company Profile
5.5.2 Novo Nordisk Business Overview
5.5.3 Novo Nordisk Anti-Obesity Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 Novo Nordisk Anti-Obesity Drugs Products Introduction
5.6 F. Hoffmann La Roche
5.6.1 F. Hoffmann La Roche Company Profile
5.6.2 F. Hoffmann La Roche Business Overview
5.6.3 F. Hoffmann La Roche Anti-Obesity Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 F. Hoffmann La Roche Anti-Obesity Drugs Products Introduction
5.7 Rhythm Pharmaceuticals
5.7.1 Rhythm Pharmaceuticals Company Profile
5.7.2 Rhythm Pharmaceuticals Business Overview
5.7.3 Rhythm Pharmaceuticals Anti-Obesity Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 Rhythm Pharmaceuticals Anti-Obesity Drugs Products Introduction
5.8 Eisai Co, Ltd.
5.8.1 Eisai Co, Ltd. Company Profile
5.8.2 Eisai Co, Ltd. Business Overview
5.8.3 Eisai Co, Ltd. Anti-Obesity Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 Eisai Co, Ltd. Anti-Obesity Drugs Products Introduction
5.9 Orexigen Therapeutics
5.9.1 Orexigen Therapeutics Company Profile
5.9.2 Orexigen Therapeutics Business Overview
5.9.3 Orexigen Therapeutics Anti-Obesity Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.9.4 Orexigen Therapeutics Anti-Obesity Drugs Products Introduction
5.10 FlaxoSithKline plc
5.10.1 FlaxoSithKline plc Company Profile
5.10.2 FlaxoSithKline plc Business Overview
5.10.3 FlaxoSithKline plc Anti-Obesity Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.10.4 FlaxoSithKline plc Anti-Obesity Drugs Products Introduction
5.11 Pfizer
5.11.1 Pfizer Company Profile
5.11.2 Pfizer Business Overview
5.11.3 Pfizer Anti-Obesity Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.11.4 Pfizer Anti-Obesity Drugs Products Introduction
5.12 Shionogi USA
5.12.1 Shionogi USA Company Profile
5.12.2 Shionogi USA Business Overview
5.12.3 Shionogi USA Anti-Obesity Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.12.4 Shionogi USA Anti-Obesity Drugs Products Introduction
5.13 Alizyme
5.13.1 Alizyme Company Profile
5.13.2 Alizyme Business Overview
5.13.3 Alizyme Anti-Obesity Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.13.4 Alizyme Anti-Obesity Drugs Products Introduction
5.14 Norgine Pharmaceuticals Ltd.
5.14.1 Norgine Pharmaceuticals Ltd. Company Profile
5.14.2 Norgine Pharmaceuticals Ltd. Business Overview
5.14.3 Norgine Pharmaceuticals Ltd. Anti-Obesity Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.14.4 Norgine Pharmaceuticals Ltd. Anti-Obesity Drugs Products Introduction
5.15 GlaxoSmithKline
5.15.1 GlaxoSmithKline Company Profile
5.15.2 GlaxoSmithKline Business Overview
5.15.3 GlaxoSmithKline Anti-Obesity Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.15.4 GlaxoSmithKline Anti-Obesity Drugs Products Introduction
5.16 BoehringerIngelheim GmbH
5.16.1 BoehringerIngelheim GmbH Company Profile
5.16.2 BoehringerIngelheim GmbH Business Overview
5.16.3 BoehringerIngelheim GmbH Anti-Obesity Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.16.4 BoehringerIngelheim GmbH Anti-Obesity Drugs Products Introduction
6 MARKET ANALYSIS AND FORECAST, BY PRODUCT TYPES
6.1 Global Anti-Obesity Drugs Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Anti-Obesity Drugs Sales and Market Share by Types (2015-2020)
6.1.2 Global Anti-Obesity Drugs Revenue and Market Share by Types (2015-2020)
6.1.3 Global Anti-Obesity Drugs Price by Types (2015-2020)
6.2 Global Anti-Obesity Drugs Market Forecast by Types (2020-2025)
6.2.1 Global Anti-Obesity Drugs Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Anti-Obesity Drugs Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Anti-Obesity Drugs Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Anti-Obesity Drugs Sales, Price and Growth Rate of Prescription Drugs
6.3.2 Global Anti-Obesity Drugs Sales, Price and Growth Rate of OTC Drugs
6.4 Global Anti-Obesity Drugs Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 Prescription Drugs Market Revenue and Sales Forecast (2020-2025)
6.4.2 OTC Drugs Market Revenue and Sales Forecast (2020-2025)
7 MARKET ANALYSIS AND FORECAST, BY APPLICATIONS
7.1 Global Anti-Obesity Drugs Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global Anti-Obesity Drugs Sales and Market Share by Applications (2015-2020)
7.1.2 Global Anti-Obesity Drugs Revenue and Market Share by Applications (2015-2020)
7.2 Global Anti-Obesity Drugs Market Forecast by Applications (2020-2025)
7.2.1 Global Anti-Obesity Drugs Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global Anti-Obesity Drugs Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global Anti-Obesity Drugs Revenue, Sales and Growth Rate of Men (2015-2020)
7.3.2 Global Anti-Obesity Drugs Revenue, Sales and Growth Rate of Women (2015-2020)
7.4 Global Anti-Obesity Drugs Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 Men Market Revenue and Sales Forecast (2020-2025)
7.4.2 Women Market Revenue and Sales Forecast (2020-2025)
8 MARKET ANALYSIS AND FORECAST, BY REGIONS
8.1 Global Anti-Obesity Drugs Sales by Regions (2015-2020)
8.2 Global Anti-Obesity Drugs Market Revenue by Regions (2015-2020)
8.3 Global Anti-Obesity Drugs Market Forecast by Regions (2020-2025)
9 NORTH AMERICA ANTI-OBESITY DRUGS MARKET ANALYSIS
9.1 Market Overview and Prospect Analysis
9.2 North America Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
9.3 North America Anti-Obesity Drugs Market Revenue and Growth Rate (2015-2020)
9.4 North America Anti-Obesity Drugs Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Anti-Obesity Drugs Market Analysis by Country
9.6.1 U.S. Anti-Obesity Drugs Sales and Growth Rate
9.6.2 Canada Anti-Obesity Drugs Sales and Growth Rate
9.6.3 Mexico Anti-Obesity Drugs Sales and Growth Rate
10 EUROPE ANTI-OBESITY DRUGS MARKET ANALYSIS
10.1 Market Overview and Prospect Analysis
10.2 Europe Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
10.3 Europe Anti-Obesity Drugs Market Revenue and Growth Rate (2015-2020)
10.4 Europe Anti-Obesity Drugs Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Anti-Obesity Drugs Market Analysis by Country
10.6.1 Germany Anti-Obesity Drugs Sales and Growth Rate
10.6.2 United Kingdom Anti-Obesity Drugs Sales and Growth Rate
10.6.3 France Anti-Obesity Drugs Sales and Growth Rate
10.6.4 Italy Anti-Obesity Drugs Sales and Growth Rate
10.6.5 Spain Anti-Obesity Drugs Sales and Growth Rate
10.6.6 Russia Anti-Obesity Drugs Sales and Growth Rate
11 ASIA-PACIFIC ANTI-OBESITY DRUGS MARKET ANALYSIS
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Anti-Obesity Drugs Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Anti-Obesity Drugs Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Anti-Obesity Drugs Market Analysis by Country
11.6.1 China Anti-Obesity Drugs Sales and Growth Rate
11.6.2 Japan Anti-Obesity Drugs Sales and Growth Rate
11.6.3 South Korea Anti-Obesity Drugs Sales and Growth Rate
11.6.4 Australia Anti-Obesity Drugs Sales and Growth Rate
11.6.5 India Anti-Obesity Drugs Sales and Growth Rate
12 SOUTH AMERICA ANTI-OBESITY DRUGS MARKET ANALYSIS
12.1 Market Overview and Prospect Analysis
12.2 South America Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
12.3 South America Anti-Obesity Drugs Market Revenue and Growth Rate (2015-2020)
12.4 South America Anti-Obesity Drugs Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Anti-Obesity Drugs Market Analysis by Country
12.6.1 Brazil Anti-Obesity Drugs Sales and Growth Rate
12.6.2 Argentina Anti-Obesity Drugs Sales and Growth Rate
12.6.3 Columbia Anti-Obesity Drugs Sales and Growth Rate
13 MIDDLE EAST AND AFRICA ANTI-OBESITY DRUGS MARKET ANALYSIS
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Anti-Obesity Drugs Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Anti-Obesity Drugs Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Anti-Obesity Drugs Market Analysis by Country
13.6.1 UAE Anti-Obesity Drugs Sales and Growth Rate
13.6.2 Egypt Anti-Obesity Drugs Sales and Growth Rate
13.6.3 South Africa Anti-Obesity Drugs Sales and Growth Rate
14 CONCLUSIONS AND RECOMMENDATIONS
14.1 Key Market Findings and Prospects
14.2 Advice for Investors
15 APPENDIX
15.1 Methodology
15.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Product Picture
Figure Global Anti-Obesity Drugs Market Size and Growth Rate 2015-2025
Table Anti-Obesity Drugs Key Market Segments
Figure Global Anti-Obesity Drugs Market Revenue ($) Segment by Type from 2015-2020
Figure Global Anti-Obesity Drugs Market Revenue ($) Segment by Applications from 2015-2020
Table SWOT Analysis
Figure Global COVID-19 Status
Figure Supply Chain
Table Major Players Headquarters, and Service Area of Anti-Obesity Drugs
Table Major Players Revenue in 2019
Figure Major Players Revenue Share in 2019
Table Vivus Company Profile
Table Vivus Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Vivus Production and Growth Rate
Figure Vivus Market Revenue ($) Market Share 2015-2020
Table Zafgen Company Profile
Table Zafgen Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Zafgen Production and Growth Rate
Figure Zafgen Market Revenue ($) Market Share 2015-2020
Table Takeda Pharmaceutical Company Profile
Table Takeda Pharmaceutical Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Takeda Pharmaceutical Production and Growth Rate
Figure Takeda Pharmaceutical Market Revenue ($) Market Share 2015-2020
Table Bristol-Myers Squibb Company Profile
Table Bristol-Myers Squibb Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Bristol-Myers Squibb Production and Growth Rate
Figure Bristol-Myers Squibb Market Revenue ($) Market Share 2015-2020
Table Novo Nordisk Company Profile
Table Novo Nordisk Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Novo Nordisk Production and Growth Rate
Figure Novo Nordisk Market Revenue ($) Market Share 2015-2020
Table F. Hoffmann La Roche Company Profile
Table F. Hoffmann La Roche Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure F. Hoffmann La Roche Production and Growth Rate
Figure F. Hoffmann La Roche Market Revenue ($) Market Share 2015-2020
Table Rhythm Pharmaceuticals Company Profile
Table Rhythm Pharmaceuticals Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Rhythm Pharmaceuticals Production and Growth Rate
Figure Rhythm Pharmaceuticals Market Revenue ($) Market Share 2015-2020
Table Eisai Co, Ltd. Company Profile
Table Eisai Co, Ltd. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Eisai Co, Ltd. Production and Growth Rate
Figure Eisai Co, Ltd. Market Revenue ($) Market Share 2015-2020
Table Orexigen Therapeutics Company Profile
Table Orexigen Therapeutics Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Orexigen Therapeutics Production and Growth Rate
Figure Orexigen Therapeutics Market Revenue ($) Market Share 2015-2020
Table FlaxoSithKline plc Company Profile
Table FlaxoSithKline plc Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure FlaxoSithKline plc Production and Growth Rate
Figure FlaxoSithKline plc Market Revenue ($) Market Share 2015-2020
Table Pfizer Company Profile
Table Pfizer Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Pfizer Production and Growth Rate
Figure Pfizer Market Revenue ($) Market Share 2015-2020
Table Shionogi USA Company Profile
Table Shionogi USA Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Shionogi USA Production and Growth Rate
Figure Shionogi USA Market Revenue ($) Market Share 2015-2020
Table Alizyme Company Profile
Table Alizyme Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Alizyme Production and Growth Rate
Figure Alizyme Market Revenue ($) Market Share 2015-2020
Table Norgine Pharmaceuticals Ltd. Company Profile
Table Norgine Pharmaceuticals Ltd. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Norgine Pharmaceuticals Ltd. Production and Growth Rate
Figure Norgine Pharmaceuticals Ltd. Market Revenue ($) Market Share 2015-2020
Table GlaxoSmithKline Company Profile
Table GlaxoSmithKline Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure GlaxoSmithKline Production and Growth Rate
Figure GlaxoSmithKline Market Revenue ($) Market Share 2015-2020
Table BoehringerIngelheim GmbH Company Profile
Table BoehringerIngelheim GmbH Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure BoehringerIngelheim GmbH Production and Growth Rate
Figure BoehringerIngelheim GmbH Market Revenue ($) Market Share 2015-2020
Table Global Anti-Obesity Drugs Sales by Types (2015-2020)
Table Global Anti-Obesity Drugs Sales Share by Types (2015-2020)
Table Global Anti-Obesity Drugs Revenue ($) by Types (2015-2020)
Table Global Anti-Obesity Drugs Revenue Share by Types (2015-2020)
Table Global Anti-Obesity Drugs Price ($) by Types (2015-2020)
Table Global Anti-Obesity Drugs Market Forecast Sales by Types (2020-2025)
Table Global Anti-Obesity Drugs Market Forecast Sales Share by Types (2020-2025)
Table Global Anti-Obesity Drugs Market Forecast Revenue ($) by Types (2020-2025)
Table Global Anti-Obesity Drugs Market Forecast Revenue Share by Types (2020-2025)
Figure Global Prescription Drugs Sales and Growth Rate (2015-2020)
Figure Global Prescription Drugs Price (2015-2020)
Figure Global OTC Drugs Sales and Growth Rate (2015-2020)
Figure Global OTC Drugs Price (2015-2020)
Figure Global Anti-Obesity Drugs Market Revenue ($) and Growth Rate Forecast of Prescription Drugs (2020-2025)
Figure Global Anti-Obesity Drugs Sales and Growth Rate Forecast of Prescription Drugs (2020-2025)
Figure Global Anti-Obesity Drugs Market Revenue ($) and Growth Rate Forecast of OTC Drugs (2020-2025)
Figure Global Anti-Obesity Drugs Sales and Growth Rate Forecast of OTC Drugs (2020-2025)
Table Global Anti-Obesity Drugs Sales by Applications (2015-2020)
Table Global Anti-Obesity Drugs Sales Share by Applications (2015-2020)
Table Global Anti-Obesity Drugs Revenue ($) by Applications (2015-2020)
Table Global Anti-Obesity Drugs Revenue Share by Applications (2015-2020)
Table Global Anti-Obesity Drugs Market Forecast Sales by Applications (2020-2025)
Table Global Anti-Obesity Drugs Market Forecast Sales Share by Applications (2020-2025)
Table Global Anti-Obesity Drugs Market Forecast Revenue ($) by Applications (2020-2025)
Table Global Anti-Obesity Drugs Market Forecast Revenue Share by Applications (2020-2025)
Figure Global Men Sales and Growth Rate (2015-2020)
Figure Global Men Price (2015-2020)
Figure Global Women Sales and Growth Rate (2015-2020)
Figure Global Women Price (2015-2020)
Figure Global Anti-Obesity Drugs Market Revenue ($) and Growth Rate Forecast of Men (2020-2025)
Figure Global Anti-Obesity Drugs Sales and Growth Rate Forecast of Men (2020-2025)
Figure Global Anti-Obesity Drugs Market Revenue ($) and Growth Rate Forecast of Women (2020-2025)
Figure Global Anti-Obesity Drugs Sales and Growth Rate Forecast of Women (2020-2025)
Figure Global Anti-Obesity Drugs Sales and Growth Rate (2015-2020)
Table Global Anti-Obesity Drugs Sales by Regions (2015-2020)
Table Global Anti-Obesity Drugs Sales Market Share by Regions (2015-2020)
Figure Global Anti-Obesity Drugs Sales Market Share by Regions in 2019
Figure Global Anti-Obesity Drugs Revenue and Growth Rate (2015-2020)
Table Global Anti-Obesity Drugs Revenue by Regions (2015-2020)
Table Global Anti-Obesity Drugs Revenue Market Share by Regions (2015-2020)
Figure Global Anti-Obesity Drugs Revenue Market Share by Regions in 2019
Table Global Anti-Obesity Drugs Market Forecast Sales by Regions (2020-2025)
Table Global Anti-Obesity Drugs Market Forecast Sales Share by Regions (2020-2025)
Table Global Anti-Obesity Drugs Market Forecast Revenue ($) by Regions (2020-2025)
Table Global Anti-Obesity Drugs Market Forecast Revenue Share by Regions (2020-2025)
Figure North America Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
Figure North America Anti-Obesity Drugs Market Revenue and Growth Rate (2015-2020)
Figure North America Anti-Obesity Drugs Market Forecast Sales (2020-2025)
Figure North America Anti-Obesity Drugs Market Forecast Revenue ($) (2020-2025)
Figure North America COVID-19 Status
Figure U.S. Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
Figure Canada Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
Figure Mexico Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
Figure Europe Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
Figure Europe Anti-Obesity Drugs Market Revenue and Growth Rate (2015-2020)
Figure Europe Anti-Obesity Drugs Market Forecast Sales (2020-2025)
Figure Europe Anti-Obesity Drugs Market Forecast Revenue ($) (2020-2025)
Figure Europe COVID-19 Status
Figure Germany Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
Figure United Kingdom Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
Figure France Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
Figure Italy Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
Figure Spain Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
Figure Russia Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Anti-Obesity Drugs Market Revenue and Growth Rate (2015-2020)
Figure Asia-Pacific Anti-Obesity Drugs Market Forecast Sales (2020-2025)
Figure Asia-Pacific Anti-Obesity Drugs Market Forecast Revenue ($) (2020-2025)
Figure Asia Pacific COVID-19 Status
Figure China Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
Figure Japan Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
Figure South Korea Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
Figure Australia Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
Figure India Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
Figure South America Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
Figure South America Anti-Obesity Drugs Market Revenue and Growth Rate (2015-2020)
Figure South America Anti-Obesity Drugs Market Forecast Sales (2020-2025)
Figure South America Anti-Obesity Drugs Market Forecast Revenue ($) (2020-2025)
Figure Brazil Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
Figure Argentina Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
Figure Columbia Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Anti-Obesity Drugs Market Revenue and Growth Rate (2015-2020)
Figure Middle East and Africa Anti-Obesity Drugs Market Forecast Sales (2020-2025)
Figure Middle East and Africa Anti-Obesity Drugs Market Forecast Revenue ($) (2020-2025)
Figure UAE Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
Figure Egypt Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
Figure South Africa Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
Figure Product Picture
Figure Global Anti-Obesity Drugs Market Size and Growth Rate 2015-2025
Table Anti-Obesity Drugs Key Market Segments
Figure Global Anti-Obesity Drugs Market Revenue ($) Segment by Type from 2015-2020
Figure Global Anti-Obesity Drugs Market Revenue ($) Segment by Applications from 2015-2020
Table SWOT Analysis
Figure Global COVID-19 Status
Figure Supply Chain
Table Major Players Headquarters, and Service Area of Anti-Obesity Drugs
Table Major Players Revenue in 2019
Figure Major Players Revenue Share in 2019
Table Vivus Company Profile
Table Vivus Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Vivus Production and Growth Rate
Figure Vivus Market Revenue ($) Market Share 2015-2020
Table Zafgen Company Profile
Table Zafgen Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Zafgen Production and Growth Rate
Figure Zafgen Market Revenue ($) Market Share 2015-2020
Table Takeda Pharmaceutical Company Profile
Table Takeda Pharmaceutical Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Takeda Pharmaceutical Production and Growth Rate
Figure Takeda Pharmaceutical Market Revenue ($) Market Share 2015-2020
Table Bristol-Myers Squibb Company Profile
Table Bristol-Myers Squibb Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Bristol-Myers Squibb Production and Growth Rate
Figure Bristol-Myers Squibb Market Revenue ($) Market Share 2015-2020
Table Novo Nordisk Company Profile
Table Novo Nordisk Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Novo Nordisk Production and Growth Rate
Figure Novo Nordisk Market Revenue ($) Market Share 2015-2020
Table F. Hoffmann La Roche Company Profile
Table F. Hoffmann La Roche Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure F. Hoffmann La Roche Production and Growth Rate
Figure F. Hoffmann La Roche Market Revenue ($) Market Share 2015-2020
Table Rhythm Pharmaceuticals Company Profile
Table Rhythm Pharmaceuticals Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Rhythm Pharmaceuticals Production and Growth Rate
Figure Rhythm Pharmaceuticals Market Revenue ($) Market Share 2015-2020
Table Eisai Co, Ltd. Company Profile
Table Eisai Co, Ltd. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Eisai Co, Ltd. Production and Growth Rate
Figure Eisai Co, Ltd. Market Revenue ($) Market Share 2015-2020
Table Orexigen Therapeutics Company Profile
Table Orexigen Therapeutics Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Orexigen Therapeutics Production and Growth Rate
Figure Orexigen Therapeutics Market Revenue ($) Market Share 2015-2020
Table FlaxoSithKline plc Company Profile
Table FlaxoSithKline plc Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure FlaxoSithKline plc Production and Growth Rate
Figure FlaxoSithKline plc Market Revenue ($) Market Share 2015-2020
Table Pfizer Company Profile
Table Pfizer Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Pfizer Production and Growth Rate
Figure Pfizer Market Revenue ($) Market Share 2015-2020
Table Shionogi USA Company Profile
Table Shionogi USA Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Shionogi USA Production and Growth Rate
Figure Shionogi USA Market Revenue ($) Market Share 2015-2020
Table Alizyme Company Profile
Table Alizyme Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Alizyme Production and Growth Rate
Figure Alizyme Market Revenue ($) Market Share 2015-2020
Table Norgine Pharmaceuticals Ltd. Company Profile
Table Norgine Pharmaceuticals Ltd. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Norgine Pharmaceuticals Ltd. Production and Growth Rate
Figure Norgine Pharmaceuticals Ltd. Market Revenue ($) Market Share 2015-2020
Table GlaxoSmithKline Company Profile
Table GlaxoSmithKline Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure GlaxoSmithKline Production and Growth Rate
Figure GlaxoSmithKline Market Revenue ($) Market Share 2015-2020
Table BoehringerIngelheim GmbH Company Profile
Table BoehringerIngelheim GmbH Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure BoehringerIngelheim GmbH Production and Growth Rate
Figure BoehringerIngelheim GmbH Market Revenue ($) Market Share 2015-2020
Table Global Anti-Obesity Drugs Sales by Types (2015-2020)
Table Global Anti-Obesity Drugs Sales Share by Types (2015-2020)
Table Global Anti-Obesity Drugs Revenue ($) by Types (2015-2020)
Table Global Anti-Obesity Drugs Revenue Share by Types (2015-2020)
Table Global Anti-Obesity Drugs Price ($) by Types (2015-2020)
Table Global Anti-Obesity Drugs Market Forecast Sales by Types (2020-2025)
Table Global Anti-Obesity Drugs Market Forecast Sales Share by Types (2020-2025)
Table Global Anti-Obesity Drugs Market Forecast Revenue ($) by Types (2020-2025)
Table Global Anti-Obesity Drugs Market Forecast Revenue Share by Types (2020-2025)
Figure Global Prescription Drugs Sales and Growth Rate (2015-2020)
Figure Global Prescription Drugs Price (2015-2020)
Figure Global OTC Drugs Sales and Growth Rate (2015-2020)
Figure Global OTC Drugs Price (2015-2020)
Figure Global Anti-Obesity Drugs Market Revenue ($) and Growth Rate Forecast of Prescription Drugs (2020-2025)
Figure Global Anti-Obesity Drugs Sales and Growth Rate Forecast of Prescription Drugs (2020-2025)
Figure Global Anti-Obesity Drugs Market Revenue ($) and Growth Rate Forecast of OTC Drugs (2020-2025)
Figure Global Anti-Obesity Drugs Sales and Growth Rate Forecast of OTC Drugs (2020-2025)
Table Global Anti-Obesity Drugs Sales by Applications (2015-2020)
Table Global Anti-Obesity Drugs Sales Share by Applications (2015-2020)
Table Global Anti-Obesity Drugs Revenue ($) by Applications (2015-2020)
Table Global Anti-Obesity Drugs Revenue Share by Applications (2015-2020)
Table Global Anti-Obesity Drugs Market Forecast Sales by Applications (2020-2025)
Table Global Anti-Obesity Drugs Market Forecast Sales Share by Applications (2020-2025)
Table Global Anti-Obesity Drugs Market Forecast Revenue ($) by Applications (2020-2025)
Table Global Anti-Obesity Drugs Market Forecast Revenue Share by Applications (2020-2025)
Figure Global Men Sales and Growth Rate (2015-2020)
Figure Global Men Price (2015-2020)
Figure Global Women Sales and Growth Rate (2015-2020)
Figure Global Women Price (2015-2020)
Figure Global Anti-Obesity Drugs Market Revenue ($) and Growth Rate Forecast of Men (2020-2025)
Figure Global Anti-Obesity Drugs Sales and Growth Rate Forecast of Men (2020-2025)
Figure Global Anti-Obesity Drugs Market Revenue ($) and Growth Rate Forecast of Women (2020-2025)
Figure Global Anti-Obesity Drugs Sales and Growth Rate Forecast of Women (2020-2025)
Figure Global Anti-Obesity Drugs Sales and Growth Rate (2015-2020)
Table Global Anti-Obesity Drugs Sales by Regions (2015-2020)
Table Global Anti-Obesity Drugs Sales Market Share by Regions (2015-2020)
Figure Global Anti-Obesity Drugs Sales Market Share by Regions in 2019
Figure Global Anti-Obesity Drugs Revenue and Growth Rate (2015-2020)
Table Global Anti-Obesity Drugs Revenue by Regions (2015-2020)
Table Global Anti-Obesity Drugs Revenue Market Share by Regions (2015-2020)
Figure Global Anti-Obesity Drugs Revenue Market Share by Regions in 2019
Table Global Anti-Obesity Drugs Market Forecast Sales by Regions (2020-2025)
Table Global Anti-Obesity Drugs Market Forecast Sales Share by Regions (2020-2025)
Table Global Anti-Obesity Drugs Market Forecast Revenue ($) by Regions (2020-2025)
Table Global Anti-Obesity Drugs Market Forecast Revenue Share by Regions (2020-2025)
Figure North America Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
Figure North America Anti-Obesity Drugs Market Revenue and Growth Rate (2015-2020)
Figure North America Anti-Obesity Drugs Market Forecast Sales (2020-2025)
Figure North America Anti-Obesity Drugs Market Forecast Revenue ($) (2020-2025)
Figure North America COVID-19 Status
Figure U.S. Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
Figure Canada Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
Figure Mexico Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
Figure Europe Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
Figure Europe Anti-Obesity Drugs Market Revenue and Growth Rate (2015-2020)
Figure Europe Anti-Obesity Drugs Market Forecast Sales (2020-2025)
Figure Europe Anti-Obesity Drugs Market Forecast Revenue ($) (2020-2025)
Figure Europe COVID-19 Status
Figure Germany Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
Figure United Kingdom Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
Figure France Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
Figure Italy Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
Figure Spain Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
Figure Russia Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Anti-Obesity Drugs Market Revenue and Growth Rate (2015-2020)
Figure Asia-Pacific Anti-Obesity Drugs Market Forecast Sales (2020-2025)
Figure Asia-Pacific Anti-Obesity Drugs Market Forecast Revenue ($) (2020-2025)
Figure Asia Pacific COVID-19 Status
Figure China Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
Figure Japan Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
Figure South Korea Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
Figure Australia Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
Figure India Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
Figure South America Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
Figure South America Anti-Obesity Drugs Market Revenue and Growth Rate (2015-2020)
Figure South America Anti-Obesity Drugs Market Forecast Sales (2020-2025)
Figure South America Anti-Obesity Drugs Market Forecast Revenue ($) (2020-2025)
Figure Brazil Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
Figure Argentina Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
Figure Columbia Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Anti-Obesity Drugs Market Revenue and Growth Rate (2015-2020)
Figure Middle East and Africa Anti-Obesity Drugs Market Forecast Sales (2020-2025)
Figure Middle East and Africa Anti-Obesity Drugs Market Forecast Revenue ($) (2020-2025)
Figure UAE Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
Figure Egypt Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
Figure South Africa Anti-Obesity Drugs Market Sales and Growth Rate (2015-2020)
